| Basic Information | |
|---|---|
| Species | Glycine max |
| Cazyme ID | Glyma13g21270.2 |
| Family | GT47 |
| Protein Properties | Length: 492 Molecular Weight: 56383 Isoelectric Point: 9.5388 |
| Chromosome | Chromosome/Scaffold: 13 Start: 24757769 End: 24764177 |
| Description | Exostosin family protein |
| View CDS | |
| External Links |
|---|
| NCBI Taxonomy |
| Plaza |
| CAZyDB |
| Signature Domain Download full data set without filtering | |||
|---|---|---|---|
| Family | Start | End | Evalue |
| GT47 | 159 | 440 | 0 |
| EKQFKVFVYEEGETPVFHNGPCKSIYSMEGNFIHAIEMNDHFRTKDPKKAHVFFLPFSVVMMVRFVYERDSRDFGPIKKTVIDYVNLIATRYPYWNRSLG ADHFMLACHDWGPEASFSLPYLHKNSIRVLCNANTSEGFKPAKDVSFPEINLQTGSINGFVGGPSASKRSILAFFAGGVHGPIRPILLEHWENKDEDIQV HKYLPKGVSYYGMLRKSKFCLCPSGYEVASPRVVEAIYTGCVPVLISEHYVPPFSDVLNWKSFSVELSVKDIPILKDILMSI | |||
| Full Sequence |
|---|
| Protein Sequence Length: 492 Download |
| MGCSSRWNCC AWWGSEAFST LKLLFLVPLI VVVGFASVKG PSLCRWGFIA DCSVSFTPLP 60 SSSNSSSQIL HQSKETEVFN VSKPEFNLAP VNKPDESHPR LKQKRKFSFL DRTEVVLAQA 120 RAAIREARNR NRTLDSDYVP TGPMYWNAKA FHRSYLEMEK QFKVFVYEEG ETPVFHNGPC 180 KSIYSMEGNF IHAIEMNDHF RTKDPKKAHV FFLPFSVVMM VRFVYERDSR DFGPIKKTVI 240 DYVNLIATRY PYWNRSLGAD HFMLACHDWG PEASFSLPYL HKNSIRVLCN ANTSEGFKPA 300 KDVSFPEINL QTGSINGFVG GPSASKRSIL AFFAGGVHGP IRPILLEHWE NKDEDIQVHK 360 YLPKGVSYYG MLRKSKFCLC PSGYEVASPR VVEAIYTGCV PVLISEHYVP PFSDVLNWKS 420 FSVELSVKDI PILKDILMSI SPRQHIRMQR RVGQIRRHFE VHSPPKRFDV FHMILHSVWL 480 RRLNFRVRDD Q* 540 |
| Functional Domains Download unfiltered results here | ||||||||
|---|---|---|---|---|---|---|---|---|
| Cdd ID | Domain | E-Value | Start | End | Length | Domain Description | ||
| pfam03016 | Exostosin | 4.0e-65 | 158 | 440 | 301 | + Exostosin family. The EXT family is a family of tumour suppressor genes. Mutations of EXT1 on 8q24.1, EXT2 on 11p11-13, and EXT3 on 19p have been associated with the autosomal dominant disorder known as hereditary multiple exostoses (HME). This is the most common known skeletal dysplasia. The chromosomal locations of other EXT genes suggest association with other forms of neoplasia. EXT1 and EXT2 have both been shown to encode a heparan sulphate polymerase with both D-glucuronyl (GlcA) and N-acetyl-D-glucosaminoglycan (GlcNAC) transferase activities. The nature of the defect in heparan sulphate biosynthesis in HME is unclear. | ||
| Gene Ontology | |
|---|---|
| GO Term | Description |
| GO:0016020 | membrane |
| Annotations - NR Download unfiltered results here | |||||||
|---|---|---|---|---|---|---|---|
| Source | Hit ID | E-Value | Query Start | Query End | Hit Start | Hit End | Description |
| DDBJ | BAB08605.1 | 0 | 102 | 489 | 20 | 407 | unnamed protein product [Arabidopsis thaliana] |
| RefSeq | NP_001031828.1 | 0 | 102 | 489 | 130 | 517 | unknown protein [Arabidopsis thaliana] |
| RefSeq | XP_002284018.1 | 0 | 158 | 487 | 1 | 330 | PREDICTED: hypothetical protein [Vitis vinifera] |
| RefSeq | XP_002326234.1 | 0 | 158 | 484 | 1 | 327 | predicted protein [Populus trichocarpa] |
| RefSeq | XP_002528630.1 | 0 | 94 | 491 | 172 | 569 | catalytic, putative [Ricinus communis] |
| Metabolic Pathways | |||
|---|---|---|---|
| Pathway Name | Reaction | EC | Protein Name |
| xylogalacturonan biosynthesis | RXN-9589 | EC-2.4.2.41 | xylogalacturonan β-1,3-xylosyltransferase |
